MedTrace Logo

Validation and Reproducibility of S.P.A.T. With Allergens

NCT05824637 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2024-02-28

No results posted yet for this study

Summary

To improve accuracy and take out human error opportunities, Hippo Dx developed S.P.A.T., an automated skin prick test. This study will provide a comparison between manual and automated skin prick test in allergic and non-allergic individuals with a panel of common inhalant allergens.

The primary endpoint is to compare the accuracy of S.P.A.T. to detect sensitization to common aeroallergens compared to a manual skin prick test (SPT).

It is a prospective monocentric study that will include 120 study participants.

Conditions

  • Allergy to House Dust
  • Allergy Pollen

Interventions

DEVICE

Skin Prick Automated Test

skin prick test to detection sensitisation to aeroallergens

DIAGNOSTIC_TEST

Skin Prick Manual Test

skin prick test to detection sensitisation to aeroallergens

Sponsors & Collaborators

  • Hippocreates

    lead INDUSTRY

Principal Investigators

  • Hendrik Sebrechts, MD · AZ Herentals

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-18
Primary Completion
2023-04-30
Completion
2023-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05824637 on ClinicalTrials.gov